Healing and tissue repair peptides are among the most actively researched categories in peptide science. These compounds work through diverse biological mechanisms — from angiogenesis and cell migration to extracellular matrix remodeling — to accelerate the body's natural repair processes. They are studied for applications ranging from tendon and ligament injuries to wound healing and gut repair.
The peptides in this guide represent the most commonly discussed healing compounds, ranked by the breadth and quality of their available evidence. It is important to note that most healing peptides lack completed human clinical trials and rely primarily on preclinical (animal) data, despite extensive off-label use in the biohacking and sports medicine communities.
Important: None of these peptides are FDA-approved for general healing purposes. They are research compounds, and their use for injury recovery should be discussed with a qualified healthcare provider. This guide is for educational purposes only and does not constitute medical advice.
BPC-157
Best for: Broad-spectrum tissue repair with the deepest preclinical evidence base
BPC-157 has the broadest preclinical evidence base of any healing peptide, with over 100 published studies demonstrating tissue repair across tendons, ligaments, muscles, the GI tract, and bone. It activates the FAK-paxillin signaling pathway and promotes angiogenesis. It is the most widely used recovery peptide in the biohacking community, though no human clinical trials have been completed.
TB-500
Best for: Wound healing and tissue repair via cell migration (extensive veterinary track record)
TB-500 (a fragment of thymosin beta-4) promotes cell migration by upregulating actin, which is essential for tissue repair and wound healing. It has extensive real-world use in veterinary medicine, particularly for racehorse injuries. Its mechanism complements BPC-157, which is why the two are commonly combined in the "Wolverine stack."
GHK-Cu
Best for: Wound healing and skin repair with actual human study data
GHK-Cu is a copper-binding tripeptide with published human studies in wound healing and dermatology — a significant evidence advantage over most peptides on this list. It stimulates collagen synthesis, activates metalloproteinases for tissue remodeling, and attracts immune cells to injury sites. Its small molecular weight allows topical absorption, making it the only healing peptide widely available in consumer skincare.
Thymosin Beta-4
Best for: Cardiac and corneal healing applications with human trial data in progress
Thymosin beta-4 is the full-length parent molecule from which TB-500 is derived. It is a 43-amino-acid peptide found throughout human tissues that plays a fundamental role in cell migration, wound healing, and anti-inflammatory signaling. It has been studied in human clinical trials for cardiac repair (post-myocardial infarction) and corneal wound healing, giving it a more advanced clinical pipeline than TB-500.
Thymosin Beta-4 Sulfoxide
Best for: Anti-inflammatory modulation in the healing cascade (specialized research use)
Thymosin beta-4 sulfoxide is an oxidized form of thymosin beta-4 that retains anti-inflammatory properties while losing some of the actin-sequestering activity of the parent molecule. It has been studied for its role in dampening inflammation at wound sites, which can accelerate the transition from inflammatory to proliferative healing phases. Research is more limited than for thymosin beta-4 or BPC-157.
Frequently asked questions
BPC-157 has the broadest preclinical evidence base for tissue repair, covering tendons, ligaments, muscles, gut, and bone. GHK-Cu has the advantage of published human studies, though primarily in dermatology. For any specific injury, the best peptide depends on the tissue type, injury severity, and whether preclinical or clinical evidence is prioritized. Consult a healthcare provider for injury-specific guidance.
Healing peptides like BPC-157 and TB-500 are widely discussed in sports medicine contexts, and preclinical data shows accelerated tendon, ligament, and muscle repair. However, they lack FDA approval for sports injuries and are banned by WADA and most sports organizations. Athletes subject to drug testing should be aware of anti-doping regulations. Use under medical supervision only.
The Wolverine stack is a popular combination of BPC-157 and TB-500, named for the comic book character's regenerative abilities. The rationale is that BPC-157 (FAK-paxillin pathway, angiogenesis) and TB-500 (actin upregulation, cell migration) promote healing through complementary mechanisms. No human clinical trials have studied this specific combination.
GHK-Cu is the primary healing peptide used topically, as its small molecular weight (340 Da) allows skin penetration. It is available in commercial skincare serums and creams. BPC-157 and TB-500 are typically administered by subcutaneous or intramuscular injection, though oral BPC-157 formulations are studied for GI tract applications.
Timelines vary by injury type and peptide. Preclinical BPC-157 studies show accelerated healing within 1-2 weeks in animal models. Real-world reports from the biohacking community typically describe noticeable improvement in 2-4 weeks for soft tissue injuries. Complete healing timelines depend on injury severity, overall health, and concurrent rehabilitation. These are not overnight solutions.